Upregulation of monocyte tissue factor activity is significantly associated with carotid intima-media thickness in patients with metabolic syndrome

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 6, 2011, Pages 475-486

  Nakagomi, Akihiro ^a   Sasaki, Mihoko ^b   Ishikawa, Youhei ^b   Shibui, Toshiyuki ^a   Kosugi, Munenori ^a   Endoh, Yasumi ^a   Morikawa, Masako ^b   Kusama, Yoshiki ^a   Atarashi, Hirotsugu ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Carotid intima media thickness; Endotoxin; Metabolic syndrome; Monocyte; Tissue factor

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOREACTIVE INSULIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; THROMBOPLASTIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CAROTID INTIMA MEDIA THICKNESS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MONOCYTES; THROMBOPLASTIN; TUNICA INTIMA; UP-REGULATION;

EID: 79959840440     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.6874     Document Type: Article

References (39)

1. Malik S, Wong ND, Franklin SS, Kamath TV, L'ItalienHJ, Pio JR, Williams GP: Impact of the metabolic syn-drome on mortality from coronary heart disease, cardio-vascular disease, and all causes in United States Adults.Circulation, 2004; 110: 1245-1250
2. Gustafson B, Hammarstedt A, Anderson CX, Smith U:Inflammed adipose tissue. A culprit underlying the meta-bolic syndrome and atherosclerosis. Arterioscler ThrombVasc Biol, 2007; 27: 2276-2283
3. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JWA,Radder JK: Elevated numbers of tissue-factor exposingmicroparticles correlate with components of the metabolicsyndrome in uncomplicated type 2 diabetes mellitus. Cir-culation, 2002; 106: 2442-2447
4. Lorenz MZ, Markus HS, Bots ML, Rosvall M, Sitzer M:Prediction of clinical cardiovascular events with carotidintima-media thickness: a systemic review and meta-anal-ysis. Circulation, 2007; 115: 459-467
5. Adams MR, Nakagomi A, Keech A, Robinson J, McCredie R, Bailey BP, Freedman SB, Celermajer DS:Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation, 1995; 92: 2127-2134
6. Cani PD, Amar J, Iglesias MA, Knauf C, Bastelica D,Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A,Delmee E, Cousin B, Sulpice T, Chamountin B, FerrieresJ, Tanti J-F, Gibson GR, Casteilla L, Delzenne NM,Alessie MC, Burcelin R: Metabolic endotoxemia initiatesobesity and insulin resistance. Diabetes, 2007; 56: 1761-1772
7. Wiedermann CJ, Kiechl S, Dunzendorfer S, SchratzbergerP, Egger G, Oberhollenzer F, Willeit J: Association ofendotoxemia with carotid atherosclerosis and cardiovascu-lar disease. Prospective results from the Bruneck Study. JAm Coll Cardiol, 1999; 34: 1975-1981
8. Nakagomi A, Sasaki M, Ishikawa Y, Morikawa M, ShibuiT, Kusama Y, Atarashi H, Mizuno K: Upregulation ofmonocyte tissue factor activity is significantly associatedwith low-grade chronic inflammation and insulin resis-tance in patients with metabolic syndrome. Circ J, 2010;74: 572-577
9. Matsuzawa Y: Metabolic syndrome-definition and diag-nostic criteria in Japan. J Atheroscler Thromb, 2005; 12:301
10. Nakagomi A, Freedman SB, Geczy CL: Intewrferon-γand lipopolysaccharide potentiate monocyte tissue factorinduction by C-reactive protein. Relationship with age,sex, and hormone replacement treatment. Circulation,2000; 101: 1785-1791
11. Esteban-Salan M, Guimon-Bardesi A, de la Viuda-Unzu-eta JM, Azcarte-Ania MN, Pascual-Usanzima P, Amoroto-Del-Rio E: Analytical and clinical evaluation of twohomogenous assays for LDL-cholesterol in hyperlipidemicpatients. Clin Chem, 2000; 46: 1121-1131
12. Song CJ, Nakagomi A, Chandar S, Cai H, Lim IGS,Mcneil HP, Freedman SB, Gezcy CL: C-reactive proteincontributes to the hypercoagulable state in coronary arterydisease. J Thromb Haemost, 2005; 3: 1-10
13. Wellen KE, Hotamisligil GS: Obseity-induced infalmma-tory changes in adipose tissue. J Clin Invest, 2003; 112:1785-1788
14. Zeyda M, Stulnig TM: Adipose tissue macrophages.Immunol Lett, 2007; 112: 61-67
15. Gustafson B: Adipose tissue, inflammation and athero-sclerosis. J Atheroscler Thromb, 2010; 30: 332-341
16. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P,Dandona P: Circulating mononuclear cells in the obeseare in a proinflammatory state. Circulation, 2004; 110:1564-1571
17. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Local-ization of tissue factor in the normal vessel wall and in theatherosclerotic plaque. Proc Natl Acad Sci USA, 1989;86: 2839-2843
18. Steffel J, Lüscher TF, Tanner FC: Tissue factor in cardio-vascular diseases. Molecular mechanisms and clinicalimplications. Circulation, 2006; 113: 722-731
19. Hasenstab D, Lea H, Hart CE, Lok S, Clowes AW.: Tissuefactor overexpression in rat arterial neointimal modelsthromobosis and progression of advanced atherosclerosis. Circulation, 2000; 101: 2651-2657
20. Sardo MA, Campo S, Mandraffino G, Saitta C, Bonaiuto A, Castaldo M, Cinquegrani M, Pizzimenti G, Saitta A: Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with or without increased carotid intima-media wall thickness. Clin Chem, 2008; 54: 814-823
21. Samad F, Pandey M, Loskutoff DJ: Regulation of tissuefactor expression in obese. Blood, 2001; 98: 3353-3358
22. Bruni F, Puccetti L, Pasqui AL, Pastorelli M, Bova G, Cer-cignani M, Palazouli A, Leo A, Auteri A: Differentialeffect induced by treatment with several statins on mono-cyte tissue factor expression in hypercholesterolemic sub-jects. Clin Exp Med, 2003; 3: 45-53
23. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P,Boden G: Effects of hyperglycemia and hyperinsulinemiaon circulating tissue factor procoagulant activity andplatelet CD40 ligand. Diabetes, 2006; 55: 202-208
24. Boden G, Vaidyula VR, Homko C, Cheung P, Rao K.: Circulating tissue factor procoagulant activity and throm-bin generation in patients with type 2 diabetes: Effects ofinsulin and glucose. J Clin Endocrinol Metab, 2006; 92: 4352-4358
25. Breitenstein A, Tanner FC, Lüscher TF: Tissue factor andcardiovascular disease: Quo Vadis? Circ J, 2010; 74: 3-12
26. Stoll LL, Denning GM, Weintraub NL: Potential role ofendotoxin as a proinflammatory mediator of atherosclero-sis. Arterioscler Thromb Vasc Biol, 2004; 24: 2227-2236
27. Miller MA, McTernan PG, Harte AL, da Silva NF, Straz-zullo P, Alberti KGMM, Kumar S, Cappuccio FP.: Ethnic and sex differences in circulating endotoxin levels: A novelmarker of atherosclerosis and cardiovascular risk in a Brit-ish multi-ethnic population. Atherosclerosis, 2009; 203:494-502
28. Ballou SP, Lozanski G: Induction of inflammatory cyto-kine release from cultured human monocytes by C-reac-tive protein. Cytokine, 1992; 4: 361-368
29. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M,Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K,Aoe S, Kamei Y, Ogawa Y: Role of the toll-like receptor4/NF-D{cyrillic}B pathway in saturated fatty acid-induced inflam-matory changes in the interaction between adipocytes andmacrophages. Arterioscler Thromb Vasc Biol, 2007; 27:84-91
30. Napoleone E, Di Santo A, Camera M, Tremoli E, Loren-zet R: Angiotensin-converting enzyme inhibitors down-regulate tissue factor synthesis in monocytes. Circ Res,2000; 86: 139-143
31. Amarenco P, Labreuche J, Lavallée P, Touboul PJ: Statinsin stroke prevention and carotid atherosclerosis. System-atic review and up-to-date meta-analysis. Stroke, 2004;35: 2902-2909
32. Pitt B, Byington RP, Furberg CD, Hunninghake DB,Mancini J, Miller ME, Riley W: for the PREVENT Inves-tigators. Circulation, 2000; 102: 1503-1510
33. Lonn EM, Yusuf S, Dzavik V, Doris I, Yi Q, Smith S,Moore-Cox A, Bosch J, Riley WA, Teo KK: For theSECURE Investigators. Effects of ramipril and vitamin Eon atherosclerosis. The study to evaluate carotid ultra-sound changes in patients treated with ramipril and vita- min E (SECURE). Circulation, 2001; 103: 919-925
34. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T,Fagard R, Messerli FH, Safar M: Carotid intima-mediathickness and antihypertensive treatment. A meta-analysisof randomized controlled trials. Stroke, 2006; 37: 1933-1940
35. Koskinen J, Kähönen M, Viikari JSA, Taittonen L,Latitinen T, Rönnemaa T, Lehtimäki T, Hutri-Kähönen N,Pietikäinen M, Jokinen E, Helenius H, Mattsson MN,Raitakari OT, Juonala M: Conventional cardiovascularrisk factors and metabolic syndrome in predicting carotidintima-media thickness progression in young adults. Thecardiovascular risk in Young Finns Study. Circulation,2009; 120: 229-236
36. Davis PH, Dawson JD, Riley WA, Lauer RM: Carotidintima-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation, 2001; 104: 2815-2819
37. Bonora E, Kiechi S, Willeit J, Oberhollenzer F, Egger G,Meigs JB, Bonadonna RC, Muggeo M: Insulin resistanceas estimated by homeostasis model assessment predictsincident symptomatic cardiovascular disease in Caucasiansubjects from the general population. Diabetes Care,2007; 30: 318-324
38. Irace C, Cortese C, Fiaschi E, Carallo C, Sesti G, FarinaroE, Gnasso A: Components of the metabolic syndromeand carotid atherosclerosis. Role of elevated blood pres-sure. Hypertension, 2005; 45: 597-601
39. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W: A rolefor tissue factor in cell adhesion and migration mediatedby interaction with actin-binding protein 280. J Cell Biol,1998; 140: 1241-1253